Heroin inhalation complicated by refractory hydrocephalus: A novel presentationAuthor Response
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Editors' Note: In response to “Heroin inhalation complicated by refractory hydrocephalus: A novel presentation,” Dastur and Chang report their own experience with a patient with delayed hydrocephalus associated with heroin inhalation. Ramos-Estebanez et al., authors of the original case report, make suggestions that may explain the differing time course of the hydrocephalus. Commenting on “Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial,” Tufan and Tufan suggest that absence of low-grade systemic inflammation in the baseline visit may have attenuated a potentially beneficial effect of etanercept on cognitive functions. They also found an …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Clinical/Scientific Notes
Heroin inhalation complicated by refractory hydrocephalus: A novel presentationDiep Ho Bui, Jonathan Pace, Sunil Manjila et al.Neurology, April 22, 2015 -
Hypotheses and Musings
Interval progression of idiopathic hypertrophic pachymeningitisNitin K. Sethi et al.Neurology: Clinical Practice, August 01, 2014 -
Resident & Fellow Section
Pearls & Oy-sters: The dangers of PRESAn atypical case with life-threatening presentationChristina Catherine, Claire Yanta, Aisha R. Saand et al.Neurology, January 14, 2019 -
Articles
C-reactive protein and familial risk for dementiaA phenotype for successful cognitive agingJeremy M. Silverman, James Schmeidler, Michal S. Beeri et al.Neurology, August 15, 2012